Built on state-of-the-art CDMO-dedicated manufacturing facilities and expert personnel, MEDIPOST provides End-to-End services spanning fast, high-quality technology transfer through to production of clinical trial materials and commercial products. Through a GMP-compliant manufacturing environment and systematic operating system, we reliably support our clients’ entire development and manufacturing process.
GMP Plant (CDMO-dedicated)
GMP Certification Status
Production Capacity (Vein-to-Vein Products)
Key Equipment
GMP Plant (CDMO-dedicated)
MEDIPOST’s GMP Plant is located at Daerung Post Tower II in Guro, Seoul, offering excellent accessibility (roughly 1 hour) to major hospitals, and is staffed by 110+ full-time GMP personnel.
3 CDMO-dedicated production suites
State-of-the-art GMP plant (completed May 2021)
Approximately 1,320 m² in area
6 suites (cleanrooms), each with independent HVAC systems
Real-time monitoring systems (Building Monitoring System, Particle Monitoring System)
Small/Middle/Large suite options selectable based on client production scale
GMP Certification Status
Under Korea’s Act on Safety and Support for Advanced Regenerative Medicine and Advanced Biopharmaceuticals, MEDIPOST holds three related licenses:
Advanced Biopharmaceutical Manufacturing License
Human Cell Management License (handles allogeneic mesenchymal stem cells and peripheral blood-derived natural killer cells; allogeneic umbilical cord blood and peripheral blood tissue)
Cell Processing Facility Registration
Most recent regular GMP inspection: December 2025
Production Capacity (Vein-to-Vein Products)
Cell therapies require production capacity suited to their unique characteristics (vein-to-vein process — collection → manufacturing → administration — and short shelf life). MEDIPOST holds production capability at the commercial stage for fresh-formulation products.
CliniMACS platform operation
99%+ production success rate (1 donor → 1 product)
≤6 hours from fill/finish to conditional product release approval
Cold chain operation
Key Equipment
MEDIPOST maintains the following key equipment, allowing client companies to use it without their own capital equipment investment:
Large-capacity centrifuge
Large-capacity incubator
Controlled rate Freezer
M1 filling machine (aseptic closed-vial filling)
Automated Cell Counter
Multi-plate bioreactor
Real-time PCR